Copayments for Prescription Drugs: The Drivers of Demand Responses

Jouko Verho and Jarkko Harju

Health Economics, 2025, vol. 34, issue 6, 1160-1170

Abstract: We study the demand responses of the drug copayment threshold in Finland using detailed prescription drug purchase data. The analysis reveals that the average drug costs increase discontinuously by 17% at the threshold above which out‐of‐pocket drug costs decrease substantially. Our results suggest an average price elasticity of −0.17, which indicates evident moral hazard costs. Approximately 80% of the overall effect is due to individuals buying drugs in larger quantities rather than purchasing higher‐priced drugs. The heterogeneity analysis suggests that the responses are largest for drug categories taken on an as‐needed rather than a regular basis.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1002/hec.4955

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wly:hlthec:v:34:y:2025:i:6:p:1160-1170

Access Statistics for this article

Health Economics is currently edited by Alan Maynard, John Hutton and Andrew Jones

More articles in Health Economics from John Wiley & Sons, Ltd.
Bibliographic data for series maintained by Wiley Content Delivery ().